Biotech Rally Moving Toward April Highs: ASCO And M&A Provides Underlying Support

Biotech stocks are pretty solid over two weeks probably anticipating ASCO news and helped by more M&A news. Since hitting a recent low of $258.90 on May 19 the IBB is up over 8% and 6% over five days to $279.77 yesterday.